FDA Approves a New Painkiller Designed to Thwart Abusers

The FDA approved a new chronic pain drug in July, the latest step in the FDA’s efforts to reduce the widespread abuse of extended-release/long-acting opioid painkillers. The drug, Targiniq ER, is for treating pain severe enough to require daily, around-the-clock, long-term treatment. It aims to treat patients who find other treatment options inadequate. Targiniq ER has properties that are … Read More